ATE204385T1 - Immunoassays unter verwendung von markierten hapten-analogen - Google Patents

Immunoassays unter verwendung von markierten hapten-analogen

Info

Publication number
ATE204385T1
ATE204385T1 AT92201582T AT92201582T ATE204385T1 AT E204385 T1 ATE204385 T1 AT E204385T1 AT 92201582 T AT92201582 T AT 92201582T AT 92201582 T AT92201582 T AT 92201582T AT E204385 T1 ATE204385 T1 AT E204385T1
Authority
AT
Austria
Prior art keywords
immunoassays
drug
analogues
labeled hapten
label
Prior art date
Application number
AT92201582T
Other languages
English (en)
Inventor
Susan Jean Danielson
Barbara A Brummond
Marsha D Oenick
Ignazio Salvatore E Ponticello
David Alan Hilborn
Original Assignee
Johnson & Johnson Clin Diag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Clin Diag filed Critical Johnson & Johnson Clin Diag
Application granted granted Critical
Publication of ATE204385T1 publication Critical patent/ATE204385T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/948—Sedatives, e.g. cannabinoids, barbiturates
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/816—Alkaloids, amphetamines, and barbiturates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Anesthesiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT92201582T 1991-06-07 1992-06-02 Immunoassays unter verwendung von markierten hapten-analogen ATE204385T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71232891A 1991-06-07 1991-06-07
US85143692A 1992-03-16 1992-03-16

Publications (1)

Publication Number Publication Date
ATE204385T1 true ATE204385T1 (de) 2001-09-15

Family

ID=27108808

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92201582T ATE204385T1 (de) 1991-06-07 1992-06-02 Immunoassays unter verwendung von markierten hapten-analogen

Country Status (5)

Country Link
US (1) US5601994A (de)
EP (1) EP0517327B1 (de)
JP (1) JP3190730B2 (de)
AT (1) ATE204385T1 (de)
DE (1) DE69232002T2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69323244T2 (de) * 1992-06-26 1999-07-08 Johnson & Johnson Clinical Diagnostics, Inc., Rochester, N.Y. Immunotests unter Verwendung von markierten Thyronin-Analogen
JP3022942B2 (ja) * 1992-08-07 2000-03-21 イーストマン コダック カンパニー 新規標識カルバマゼピン類似体
US5650324A (en) 1994-05-31 1997-07-22 Johnson & Johnson Clinical Diagnostics, Inc. Inhibitor and anti-inhibitor monoclonal antibodies specific for horseradish peroxidase
US5565326A (en) 1994-05-31 1996-10-15 Johnson & Johnson Clinical Diagnostics, Inc. Separation-free specific binding assays using anti-inhibitor antibodies
US5589344A (en) * 1994-06-15 1996-12-31 Johnson & Johnson Clinical Diagnostics, Inc. Test kit and method for competitive specific binding assay
AU697785B2 (en) 1994-07-19 1998-10-15 Johnson & Johnson Clinical Diagnostics, Inc. Analytical element,composition and method using modified apo-horseradish peroxidase
ES2167278B1 (es) * 2000-10-24 2003-08-16 Univ Murcia Enzima con actividad peroxidasa aislada de la alcachofa (cynara scolymus, l.) procedimiento para su aislamiento y purificacion y aplicaciones.
US8133743B2 (en) 2007-10-19 2012-03-13 Roche Diagnostics Operations, Inc. Phenobarbital derivatives useful in immunoassay
WO2014031645A1 (en) 2012-08-21 2014-02-27 Ortho-Clinical Diagnostics, Inc Antibodies to risperidone haptens and use thereof
US20140057303A1 (en) 2012-08-21 2014-02-27 Janssen Pharmaceutica Nv Antibodies to Olanzapine Haptens and Use Thereof
PT3462173T (pt) 2012-08-21 2021-04-28 Janssen Pharmaceutica Nv Anticorpos contra risperidona e utilização dos mesmos
HK1211958A1 (en) 2012-08-21 2016-06-03 Ortho-Clinical Diagnostics, Inc. Antibodies to paliperidone and use thereof
CA2882489A1 (en) 2012-08-21 2014-02-27 Ortho-Clinical Diagnostics, Inc. Antibodies to paliperidone haptens and use thereof
AU2016372069A1 (en) 2015-12-17 2018-06-07 Saladax Biomedical Inc. Antibodies to risperidone and use thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3875011A (en) * 1972-11-06 1975-04-01 Syva Co Enzyme immunoassays with glucose-6-phosphate dehydrogenase
US4065354A (en) * 1974-10-10 1977-12-27 Syva Company Lysozyme conjugates for enzyme immunoassays
US4213964A (en) * 1978-12-07 1980-07-22 Miles Laboratories, Inc. Diphenylhydantoin antibodies
IL59065A0 (en) * 1979-01-18 1980-05-30 Beecham Group Ltd Hydantoin derivatives,their preparation pharmaceutical compositons containing them
US4404366A (en) * 1980-05-06 1983-09-13 Miles Laboratories, Inc. Beta-galactosyl-umbelliferone-labeled hapten conjugates
NZ199629A (en) * 1981-02-17 1984-11-09 Abbott Lab Fluorescent polarisation immunoassay and certain substituted carboxy fluoresceins
US4378428A (en) * 1981-03-30 1983-03-29 Baker Instruments Corporation Method for carrying out non-isotopic immunoassays, labeled analytes and kits for use in such assays
US4447529A (en) * 1981-07-06 1984-05-08 Miles Laboratories, Inc. Preparing homogeneous specific binding assay element to avoid premature reaction
US4752568A (en) * 1986-01-13 1988-06-21 Eastman Kodak Company Labeled hydantoin conjugate and its use in analytical element and immunoassays
CA1300499C (en) * 1987-08-03 1992-05-12 Susan J. Danielson Water-insoluble reagent, elements containing same and methods of use
DE69030829T2 (de) * 1989-03-10 1998-01-15 Hoffmann La Roche Reagenzien zum Nachweis von Drogen
US5096838A (en) * 1989-11-27 1992-03-17 Abbott Laboratories Barbiturate assay compositions and methods
US5162219A (en) * 1990-06-18 1992-11-10 Eastman Kodak Company Preparation of amine-enriched proteins having an increased isoelectric point

Also Published As

Publication number Publication date
EP0517327B1 (de) 2001-08-16
US5601994A (en) 1997-02-11
EP0517327A2 (de) 1992-12-09
DE69232002D1 (de) 2001-09-20
EP0517327A3 (en) 1993-05-05
JP3190730B2 (ja) 2001-07-23
JPH0627108A (ja) 1994-02-04
DE69232002T2 (de) 2002-06-06

Similar Documents

Publication Publication Date Title
DE69232002D1 (de) Immunoassays unter Verwendung von markierten Hapten-Analogen
DE68919565D1 (de) Immuntestverfahren unter Verwendung magnetischer Markerteilchen.
ATE233003T1 (de) Verfahren und gerät zum automatischen zusammenfassen von texten
NO851516L (no) Krysstang-kvadrupolkilde for akustisk broennlogging.
FR2624719B1 (fr) Sonde de percage, en particulier pour positionner et fixer un clou medullaire
EP0627932A4 (de) Neuartige antikörperkonstrukte.
FI20040608A7 (fi) Virtsasta peräisin oleva uusi proteiini, jota kutsutaan komponentti B:ksi
DE69333569D1 (de) Magnetisch assistierte bindungsassays unter verwendung von magnetisch markierten bindungspartnern.
DE68922243D1 (de) Immuntest für HIV-1-Antigene unter Benutzung von F(AB')2-Fragmenten als Sonde.
KR890006584A (ko) 헤테로이작용성 커플링제
ATE208042T1 (de) Hapten-analoge zur verwendung in immunoassays
ATE134039T1 (de) Analyse von hämoglobinvarianten durch kapillarelektroforese
FR2702105B1 (fr) Dispositif de régulation de la tension de mode commun en sortie d'un amplificateur équilibré.
FI874280A7 (fi) Immuunimääritysmenetelmä.
DE69021036D1 (de) Test-Anordnungssystem für integrierte Schaltungen unter Verwendung von lateralen Transistoren.
ATE204384T1 (de) Markierte hapten-analoge zur verwendung in immunoassays
DE68914094D1 (de) Immunoanalyseverfahren.
ATE176329T1 (de) Immunotests unter verwendung von markierten thyronin-analogen
DE69021921D1 (de) Monoklonale Antikörper gegen den C-Terminus von ANP.
FI892257A0 (fi) Anordning foer infoerande, pressning och uttagning av ett skiktpaket i resp. ur en varmpress.
NO890116L (no) Monoklonale antistoffer.
DE69008406D1 (de) N-Hydroxycarbyloxy-Derivate von s-Triazinen mit gehinderter Aminogruppe.
ATE161962T1 (de) Immunoassays unter verwendung von, mit meerrettich-peroxidase markierten carbamazepin- analogen
DE69000908D1 (de) Leichtes transportables brueckenteil zur ueberwindung von graeben.
FI893928A7 (fi) Monoklonala motkroppar.